BOSTON BIOMEDICAL RES INST has a total of 33 patent applications. Its first patent ever was published in 1998. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and machines are EMERY DARYLL A, IMREG INC and JENNER TECHNOLOGIES.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 16 | |
#2 | WIPO (World Intellectual Property Organization) | 11 | |
#3 | Canada | 3 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | Australia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Machines | |
#4 | Measurement | |
#5 | Foods and drinks | |
#6 | Agriculture |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Microorganisms | |
#5 | Unspecified technologies | |
#6 | Analysing materials | |
#7 | Enzymes | |
#8 | Animal care | |
#9 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Raso Victor | 15 |
#2 | Ai Xingbin | 5 |
#3 | Gonzalez Ruben Rene | 3 |
#4 | Li Yunping | 3 |
#5 | Leavis Paul C | 3 |
#6 | Erhardt Peter | 3 |
#7 | Toth Ambrus | 3 |
#8 | Morgan Kathleen | 3 |
#9 | Emerson Charles P Jr | 3 |
#10 | Henry Paulus | 2 |
Publication | Filing date | Title |
---|---|---|
WO2012087835A2 | Compositions and methods for enhancing protein folding | |
WO2009011892A2 | Use of suif proteins and heparan sulfate in gdnf-dependent neural innervation and protection | |
WO2008079324A1 | Immunological modulation of insulin-like growth factor 1 for cancer prevention/treatment and prolonging longevity | |
WO2007067514A2 | Methods for identifying modulators of hedgehog autoprocessing | |
WO2007092023A1 | Compositions and methods for binding or inactivating ghrelin | |
US2006217381A1 | Methods and compositions for specific inhibition of protein splicing by small molecules | |
US2005250724A1 | Methods for preventing or reducing ischemia/reperfusion induced myocardial cell death | |
WO2005079390A2 | Inhibition of fgf signaling | |
US2005250690A1 | Leptin peptide antagonists | |
US2005014676A1 | Methods for delaying or inducing labor | |
AU5742100A | Immunological control of beta-amyloid levels in vivo | |
US6140091A | Anti-idiotype vaccines to elicit catalytic antibodies |